Database : MEDLINE
Search on : Lip and Diseases [Words]
References found : 5652 [refine]
Displaying: 1 .. 10   in format [Detailed]

page 1 of 566 go to page                         

  1 / 5652 MEDLINE  
              next record last record
select
to print
Photocopy

[PMID]: 18661066
[Au] Autor:Liu XF; Pan XG; Shu R
[Ad] Address:Department of Periodontology, Ninth People's Hospital, College of Stomatology, School of Medicine, Shanghai Jiao Tong University. Shanghai 200011, China.
[Ti] Title:[A preliminary study of combined periodontal-orthodontic approach for treating labial displacement of incisors in patients with periodontal diseases].
[So] Source:Shanghai Kou Qiang Yi Xue;17(3):264-6, 2008 Jun.
[Is] ISSN:1006-7248
[Cp] Country of publication:China
[La] Language:chi
[Ab] Abstract:PURPOSE: The purpose of this study was to evaluate the effect of combined periodontal-orthodontic treatment for patients who had chronic periodontitis with labial displacement of incisors and radiological evidence on migrated incisors. METHODS: Twenty-one adult patients were included in the study. Fifty-two migrated incisors were randomly assigned to treatment with circumferential supracrestal fibrotomy or non-surgery. The mean orthodontic treatment time was 12 months. Before surgery (circumferential supracrestal fibrotomy) and at the end of orthodontic treatment, the following parameters were registered clinically: CAL(clinical attachment loss), TM(tooth mobility), SBI (sulcus bleeding index), PD (probing depth),CEJAC (distance from the CEJ to the alveolar crest) and RL (root length). Standardized intraoral radiographs were taken. SPSS12.0 software package was used for data analysis. Student's t test was performed for coupled data including PD, CAL, CEJAC and RL. Results of SBI and TM were analyzed statistically with Wilcoxon signed rank test. RESULTS: Comparison of pre- and post-treatment values showed a statistically significant improvement for all parameters without remarkable root apex resorption. TM and CAL reduction were greater in the surgical group compared to the non-surgical group (P<0.05). The reduction of CEJAC between the two groups were significantly different (P<0.01). CONCLUSION: The results show the efficacy of combined periodontal-orthodontic approach with circumferential fibrotomy on patients with incisors migration. After proper periodontal surgical therapy, orthodontic movement can positively improve both the alveolar bone and the soft periodontal tissues.
[Mh] MeSH terms primary: Chronic Periodontitis/surgery
Orthodontic Appliances
[Mh] MeSH terms secundary: Adult
Alveolar Bone Loss
Humans
Incisor
Lip
Tooth Migration
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
[Em] Entry month:1505
[Js] Journal subset:D; IM
[Da] Date of entry for processing:080728
[St] Status:MEDLINE

  2 / 5652 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 23520775
[Au] Autor:Liang C; Wang X; Yi B; Li ZL; Wang XX
[Ad] Address:Department of Oral and Maxillofacial Surgery, Stomatological Hospital, Peking University, Beijing 100081, China.
[Ti] Title:[The treatment of mandibular micrognathia secondary to temporomandibular joint ankylosis with distraction osteogenesis].
[So] Source:Zhonghua Zheng Xing Wai Ke Za Zhi;28(6):416-20, 2012 Nov.
[Is] ISSN:1009-4598
[Cp] Country of publication:China
[La] Language:chi
[Ab] Abstract:OBJECTIVE: To evaluate the clinical effect of distraction osteogenesis for patients with mandibular micrognathia secondary to temporomandibular joint (TMJ) ankylosis. METHODS: 43 patients (aged from 2 to 61 years old) with mandibular micrognathia were treated with mandibular distraction osteogenesis. Two types of mechanical distraction were utilized in this study. Ten patients (age ranged from 2 to 16-years-old, mean age 7.6 years old) with severe micrognathia underwent bilateral mandibular distraction with rigid external distraction (RED) device. Other 33 patients were treated with unilateral(6 cases) or bilateral (27 cases) mandibular distraction using internal distraction device. Distraction was started on the 4th to 8th day after operation and distraction rate was 0.25 mm every time, four times a day. Distractor was removed after 3 to 6 months of consolidation period. RESULTS: Eighty sides of mandible in 43 patients were lengthened. The mean distraction distance was 23.2 mm (ranged from 14 to 35 mm). After distraction, the average posterior airway space (PAS) was enlarged from 4.9 mm to 10.4 mm and average angle of sella-nasion-point B (SNB) was increased from 64.2 degrees to 74.5 degrees. The apnea hypopnea index (AHI) was decrease significantly. The profile was improved and OSA was improved effectively in each patient. No complication occurred during treatment. No persistent numbness of lower lip was observed. All patients were satisfied with the results. After a mean follow-up period of 20.3 months(5 to 103 months) , the result was stable and no obvious relapse of micrognathia was observed. CONCLUSIONS: Distraction osteogenesis is an effective way in correction of mandibular micrognathia secondary to TMJ ankylosis. RED is a new method for treatment of children and adolescence with severe mandibular micrognathia. The procedure is simple and safe with stable result.
[Mh] MeSH terms primary: Ankylosis/complications
Mandible/surgery
Micrognathism/surgery
Osteogenesis, Distraction/methods
Temporomandibular Joint Disorders/complications
[Mh] MeSH terms secundary: Adolescent
Adult
Child
Child, Preschool
Humans
Micrognathism/etiology
Middle Aged
Osteogenesis, Distraction/instrumentation
Sleep Apnea, Obstructive/surgery
Temporomandibular Joint
Young Adult
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Em] Entry month:1505
[Js] Journal subset:IM
[Da] Date of entry for processing:130325
[St] Status:MEDLINE

  3 / 5652 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 24628407
[Au] Autor:Misago N; Takai T; Murata Y; Nagase K; Narisawa Y
[Ad] Address:Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
[Ti] Title:Cases with a spontaneous regression of an infiltrating non-crateriform keratoacanthoma and squamous cell carcinoma with a keratoacanthoma-like component.
[So] Source:J Dermatol;41(5):430-4, 2014 May.
[Is] ISSN:1346-8138
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:We herein report the natural course of an early/proliferative stage keratoacanthoma (KA) with infiltrating islands of cytological malignancy (case 1) and a squamous cell carcinoma (SCC) with a KA-like component (case 2), which were observed until their complete regression. The presented case 1 suggests that one of the histopathological forms of KA includes this unusual, infiltrating, non-crateriform architecture, and also indicates the possibility of complete remission in the KA associated with infiltrating islands of cytological malignancy. In the presented case 2, the peripherally-associated KA-like focus was histopathologically considered to be either a remnant of KA focus or verrucous keratosis (hyperplasia). Therefore, the complete spontaneous regression of case 2 suggests that SCC arising in KA still has the potential of spontaneous regression, or that an extremely rare event, namely, the spontaneous regression of (traditional) SCC occurred in the present case.
[Mh] MeSH terms primary: Carcinoma, Squamous Cell/pathology
Keratoacanthoma/pathology
Neoplasm Regression, Spontaneous/pathology
Skin Diseases/pathology
Skin Neoplasms/pathology
[Mh] MeSH terms secundary: Adult
Aged, 80 and over
Carcinoma, Squamous Cell/complications
Female
Humans
Keratoacanthoma/complications
Keratosis/complications
Keratosis/pathology
Lip Diseases/complications
Lip Diseases/pathology
Lip Neoplasms/complications
Lip Neoplasms/pathology
Skin Diseases/complications
Skin Neoplasms/complications
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Em] Entry month:1505
[Js] Journal subset:IM
[Da] Date of entry for processing:140507
[St] Status:MEDLINE
[do] DOI:10.1111/1346-8138.12454

  4 / 5652 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 25618553
[Au] Autor:Lazzerini M; Martelossi S; Cont G; Bersanini C; Ventura G; Fontana M; Zuin G; Ventura A; Taddio A
[Ad] Address:Institute for Maternal and Child Health, IRCCS "Burlo Garofolo", Trieste, Italy....
[Ti] Title:Orofacial granulomatosis in children: think about Crohn's disease.
[So] Source:Dig Liver Dis;47(4):338-41, 2015 Apr.
[Is] ISSN:1878-3562
[Cp] Country of publication:Netherlands
[La] Language:eng
[Ab] Abstract:BACKGROUND: The term orofacial granulomatosis is conventionally used to describe patients with granulomatous lesions affecting the orofacial tissues, in absence of intestinal lesions. Lip swelling and facial swelling are the most common clinical signs. Despite the fact that histologically it is not distinguishable from Crohn's disease, and that both diseases have a chronic/recurrent course, the relationship between orofacial granulomatosis and Crohn's disease is still debated. METHODS: Herein we present five cases of orofacial granulomatosis. RESULTS: All patients presented concomitant Crohn's disease, supporting the hypothesis that orofacial granulomatosis and Crohn's disease may be one single disease. Thalidomide was effective in inducing remission of oral and intestinal symptoms in all five cases and could be considered a valid treatment opportunity for these patients. CONCLUSIONS: Orofacial granulomatosis and Crohn's disease may be part of the same disease; both may respond to thalidomide.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1503
[Js] Journal subset:IM
[St] Status:In-Process

  5 / 5652 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 25616597
[Au] Autor:Vachirayonsti T; Ho KW; Yang D; Yan B
[Ad] Address:Department of Biomedical and Pharmaceutical Sciences, Center for Pharmacogenomics and Molecular Therapy, University of Rhode Island, Kingston, Rhode Island 02881....
[Ti] Title:Suppression of the pregnane X receptor during endoplasmic reticulum stress is achieved by down-regulating hepatocyte nuclear factor-4α and up-regulating liver-enriched inhibitory protein.
[So] Source:Toxicol Sci;144(2):382-92, 2015 Apr.
[Is] ISSN:1096-0929
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Endoplasmic reticulum (ER) stress is recognized as a common theme in the development of metabolic syndrome and other diseases. Chronic liver diseases develop ER stress and also show decreased capacity of drug metabolism. The pregnane X receptor (PXR) is a master regulator of genes involved in drug elimination. This study was performed to determine whether ER stress condition decreases the expression of PXR and whether the decrease alters the induction of cytochrome P450 3A4 (CYP3A4). Human primary hepatocytes and HepG2 cell line (human hepatocellular carcinoma) were treated with brefeldin A and thapsigargin, 2 well-established ER stressors. Without exceptions, both stressors significantly decreased the expression of PXR. The decrease led to reduced induction of CYP3A4. Reporter dissection study, electrophoretic mobility shift assay, and chromatin immunoprecipitation located in the PXR promoter region 2 adjacent elements recognized by hepatocyte nuclear factor-4α (HNF-4α) and cytidine-cytidine-adenosine-adenosine-thymidine enhanced binding proteins (C/EBPs), respectively. Additional studies demonstrated that HNF-4α was down-regulated during ER stress but the expression of C/EBP varied depending on a particular form of C/EBP. Liver-enriched activator protein (LAP) was down-regulated but liver-enriched inhibitory protein (LIP) was highly induced. Nevertheless, over-expression of HNF-4α or LAP restored the expression of PXR. Interestingly, the very same sequence also responded to interleukin-6 (IL-6), and primary hepatocytes treated with thapsigargin significantly increased the level of IL-6 mRNA. These findings establish a functional interconnection between ER stress and signaling of proinflammatory cytokines in the regulation of PXR expression.
[Pt] Publication type:JOURNAL ARTICLE; RESEARCH SUPPORT, N.I.H., EXTRAMURAL
[Em] Entry month:1503
[Cu] Class update date: 150328
[Lr] Last revision date:150328
[Js] Journal subset:IM
[St] Status:In-Process
[do] DOI:10.1093/toxsci/kfv008

  6 / 5652 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 24836447
[Au] Autor:Sabet-Peyman EJ; Woodward JA
[Ad] Address:Department of Oculoplastics, Duke Eye Center, Durham, North Carolina, U.S.A.
[Ti] Title:A case series of patients diagnosed with orofacial granulomatosis presenting primarily with dense infiltrates and severe periorbital edema.
[So] Source:Ophthal Plast Reconstr Surg;30(6):e151-5, 2014 Nov-Dec.
[Is] ISSN:1537-2677
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Orofacial granulomatosis is a relapsing nonnecrotizing granulomatous syndrome that classically presents with lip and perioral swelling. Over the years, several patients have been referred to the Duke Eye Center Oculoplastics Department for severe, progressive, recurrent eyelid swelling interfering with both their functional vision and their appearance. In this IRB approved retrospective case series, we describe the clinical course of 5 such patients, including their presenting symptoms, diagnosis, and response to treatment. We hope that oculoplastics specialists will consider this entity in the differential diagnosis of periorbital edema and consider initiating localized anti-inflammatory treatment once the diagnosis has been made.
[Mh] MeSH terms primary: Edema/diagnosis
Eyelid Diseases/diagnosis
Melkersson-Rosenthal Syndrome/diagnosis
[Mh] MeSH terms secundary: Adolescent
Adult
Aged
Drug Therapy, Combination
Edema/drug therapy
Eyelid Diseases/drug therapy
Glucocorticoids/therapeutic use
Humans
Immunosuppressive Agents/therapeutic use
Male
Melkersson-Rosenthal Syndrome/drug therapy
Methotrexate/therapeutic use
Middle Aged
Prednisolone/therapeutic use
Triamcinolone Acetonide/therapeutic use
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Nm] Name of substance:0 (Glucocorticoids); 0 (Immunosuppressive Agents); 9PHQ9Y1OLM (Prednisolone); F446C597KA (Triamcinolone Acetonide); YL5FZ2Y5U1 (Methotrexate)
[Em] Entry month:1505
[Js] Journal subset:IM
[Da] Date of entry for processing:141111
[St] Status:MEDLINE
[do] DOI:10.1097/01.iop.0000440702.85663.e5

  7 / 5652 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 25148283
[Au] Autor:Shi VY; Joo JS; Sharon VR
[Ti] Title:Multiple labial melanotic macules occurring after topical application of calcineurin inhibitors.
[So] Source:Dermatol Online J;20(8), 2014 Aug.
[Is] ISSN:1087-2108
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Topical calcineurin inhibitors are widely used to treat inflammatory dermatoses for their steroid-sparing advantage. Herein, we report a patient with chronic lip dermatitis who developed multiple labial melanotic macules after application of tacrolimus 0.1% ointment and pimecrolimus 1% cream. Prior and current reports raise concerns for potential development of pigmented lesions associated with topical calcineurin inhibitor use. These reports highlight the need for careful risk-benefit assessment when prescribing topical calcineurin inhibitors for inflammatory dermatoses, especially when used on sun-exposed sites.
[Mh] MeSH terms primary: Calcineurin Inhibitors/adverse effects
Dermatitis, Atopic/drug therapy
Lentigo/chemically induced
Lip Diseases/chemically induced
Tacrolimus/analogs & derivatives
[Mh] MeSH terms secundary: Administration, Cutaneous
Adult
Biopsy
Calcineurin Inhibitors/administration & dosage
Diagnosis, Differential
Female
Humans
Lentigo/pathology
Lip Diseases/pathology
Peptidylprolyl Isomerase/antagonists & inhibitors
Tacrolimus/administration & dosage
Tacrolimus/adverse effects
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Nm] Name of substance:0 (Calcineurin Inhibitors); 7KYV510875 (pimecrolimus); EC 5.2.1.8 (Peptidylprolyl Isomerase); WM0HAQ4WNM (Tacrolimus)
[Em] Entry month:1505
[Js] Journal subset:IM
[Da] Date of entry for processing:140823
[St] Status:MEDLINE

  8 / 5652 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
PubMed Central Full text
Full text

[PMID]: 24777193
[Au] Autor:Ma Q; Li D; Carreo R; Patenia R; Tsai KY; Xydes-Smith M; Alousi AM; Champlin RE; Sale GE; Afshar-Kharghan V
[Ad] Address:Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA....
[Ti] Title:Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD.
[So] Source:Bone Marrow Transplant;49(7):972-6, 2014 Jul.
[Is] ISSN:1476-5365
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:The complement system has been shown to regulate T-cell activation and alloimmune responses in GVHD. Mice deficient in the central component of complement system C3 have significantly lower GVHD-related mortality/morbidity, and C3 modulates Th1/Th17 polarization in mouse GVHD. To investigate whether anticomplement therapy has any impact on human T-cell activation, a drug candidate Compstatin was used to inhibit C3 activation in this study. We found the frequency of IFN-γ (Th1)-, IL-4 (Th2)-, IL-17 (Th17)-, IL-2- and TNF-α-producing cells were significantly reduced among activated CD4(+) cells in the presence of Compstatin. Compstatin treatment decreased the proliferation of both CD4(+) and CD8(+) T cells upon TCR stimulation. However, Compstatin does not affect the production of IL-2 and TNF-α in activated CD8(+) T cells, and the differentiation of CD8(+) T cells into distinct memory and effector subsets remained intact. Furthermore, we examined complement deposition in skin and lip biopsy samples of patients diagnosed with cutaneous GVHD. C3 deposition was detected in the squamous epithelium and dermis, blood vessels and damaged sweat glands, and was associated with gland damage and regeneration. We conclude that C3 mediates Th1/Th17 polarization in human T-cell activation and skin GVHD in patients.
[Mh] MeSH terms primary: Complement C3/immunology
Skin Diseases/immunology
Th1 Cells/immunology
Th17 Cells/immunology
[Mh] MeSH terms secundary: Animals
Cell Differentiation/immunology
Cytokines/biosynthesis
Disease Models, Animal
Flow Cytometry
Graft vs Host Disease/immunology
Humans
Lymphocyte Activation
Mice
[Pt] Publication type:JOURNAL ARTICLE; RESEARCH SUPPORT, N.I.H., EXTRAMURAL; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Name of substance:0 (Complement C3); 0 (Cytokines)
[Em] Entry month:1504
[Cu] Class update date: 150514
[Lr] Last revision date:150514
[Js] Journal subset:IM
[Da] Date of entry for processing:140702
[St] Status:MEDLINE
[do] DOI:10.1038/bmt.2014.75

  9 / 5652 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 25480402
[Au] Autor:Zhang R; Chen X; Zhang S; Zhang X; Li T; Liu Z; Wang J; Zang W; Wang Y; Du Y; Zhao G
[Ad] Address:College of Basic Medical Sciences, Zhengzhou University, No. 100 Kexue Road, Zhengzhou, 450001, Henan, China.
[Ti] Title:Upregulation of miR-494 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis by Targeting Cleft Lip and Palate Transmembrane 1-Like in Esophageal Squamous Cell Carcinoma.
[So] Source:Dig Dis Sci;60(5):1247-55, 2015 May.
[Is] ISSN:1573-2568
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:BACKGROUND: Potential target genes of microRNA (miR)-494 have been reported in many types of cancers. However, the role of miR-494 in esophageal squamous cell carcinoma (ESCC) remains unknown. AIM: This study focused on the expression and biological function of miR-494 in ESCC. METHODS: Using bioinformatics analyses, we found that cleft lip and palate transmembrane 1-like (CLPTM1L) was a potential target of miR-494. We performed quantitative real-time (qRT) PCR assays in 37 ESCC tumor tissues to determine the expression of miR-494 and CLPTM1L mRNA, and we analyzed the correlation between both of these factors and clinical characteristics. The cell counting kit-8 and colony formation assays were used to evaluate the effects of miR-494 expression on the proliferation of ESCC cells. The transwell migration assay and flow cytometric apoptosis assay were performed to study the influence of miR-494 on the invasion and apoptosis of ESCC cells. Western blotting, luciferase assays, and CLPTM1L knockdown experiments were used to determine whether CLPTM1L was a target of miR-494. RESULTS: The qRT-PCR assays showed significant downregulation of miR-494 (P<0.05) and upregulation of CLPTM1L mRNA (P<0.05), both of which were significantly associated with lymph node metastases (P<0.05). High expression of miR-494 inhibited cell proliferation and invasion and promoted cell apoptosis (P<0.05). The results also showed that CLPTM1L was a target of miR-494. CONCLUSION: These results show that the expression of miR-494, which can regulate cell growth, invasion and apoptosis of ESCC cells by targeting CLPTM1L, is downregulated in ESCC tumor tissues. The miR-494-CLPTM1L pathway could be further exploited to develop a new approach to treat ESCC.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1505
[Js] Journal subset:AIM; IM
[St] Status:In-Data-Review
[do] DOI:10.1007/s10620-014-3433-7

  10 / 5652 MEDLINE  
              first record previous record
select
to print
Photocopy
Full text

[PMID]: 25219684
[Au] Autor:Bezerra JF; Oliveira GH; Soares CD; Cardoso ML; Ururahy MA; Neto FP; Lima-Neto LG; Luchessi AD; Silbiger VN; Fajardo CM; Oliveira SR; Almeida Md; Hirata RD; Rezende AA; Hirata MH
[Ad] Address:Department of Clinical and Toxicological Analysis, Federal University of Rio Grande do Norte, Natal, RN, Brazil.
[Ti] Title:Genetic and non-genetic factors that increase the risk of non-syndromic cleft lip and/or palate development.
[So] Source:Oral Dis;21(3):393-9, 2015 Apr.
[Is] ISSN:1601-0825
[Cp] Country of publication:Denmark
[La] Language:eng
[Ab] Abstract:OBJECTIVES: We investigated the relationship between non-syndromic cleft lip/palate (NSCLP) and polymorphisms in methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and RFC1, as well as the corresponding interactions with environmental factors. SUBJECTS AND METHODS: One hundred and forty NSCLP patients and their mothers, as well as 175 control individuals and their mothers, were recruited. Information regarding smoking and alcohol consumption was recorded. Blood samples were obtained in order to measure serum folate and cobalamin, as well as, plasma total homocysteine concentrations and to extract DNA. Polymorphisms in MTHFR(677C>T and 1298A>C), MTR(2756A>G), MTR(66A>G), and RFC1(80A>G) were analyzed by PCR-restriction fragment length polymorphism. RESULTS: Among the patients, 59.5% had cleft lip and palate, 22.0% had cleft palate, and 18.5% had cleft lip only. Maternal alcohol consumption and reduced folic acid concentrations in both children and mothers (P<0.001 and P=0.003, respectively) were risk factors for NSCLP. Patients and their mothers carrying the MTHFR 667T allele showed lower serum folate than CC (P=0.011 and P=0.030, respectively). Mothers who carried the MTHFR 1298C allele exhibited increased risk of having a child with NSCLP, after adjusting for alcohol consumption (OR: 1.75, 95% CI: 1.03-2.99, P=0.038). CONCLUSIONS: Reduced folic acid levels, alcohol consumption, and the MTHFR 677T and 1298C alleles may have contributed to NSCLP development in this sample population from Rio Grande do Norte.
[Pt] Publication type:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Em] Entry month:1503
[Js] Journal subset:D
[St] Status:In-Process
[do] DOI:10.1111/odi.12292


page 1 of 566 go to page                         
   


Refine the search
  Database : MEDLINE Advanced form   

    Search in field  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information